Céline Godfroid

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


4 publications

2024 | 2021 | 2020 |
Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy.
Leavitt R.J., Almeida A., Grilj V., Montay-Gruel P., Godfroid C., Petit B., Bailat C., Limoli C.L., Vozenin M.C., 2024/08/01. International journal of radiation oncology, biology, physics, 119 (5) pp. 1493-1505. Peer-reviewed.
Antitumor Effect by Either FLASH or Conventional Dose Rate Irradiation Involves Equivalent Immune Responses.
Almeida A., Godfroid C., Leavitt R.J., Montay-Gruel P., Petit B., Romero J., Ollivier J., Meziani L., Sprengers K., Paisley R. et al., 2024/03/15. International journal of radiation oncology, biology, physics, 118 (4) pp. 1110-1122. Peer-reviewed.
 
CD40 Agonist Targeted to Fibroblast Activation Protein α Synergizes with Radiotherapy in Murine HPV-Positive Head and Neck Tumors.
Labiano S., Roh V., Godfroid C., Hiou-Feige A., Romero J., Sum E., Rapp M., Boivin G., Wyss T., Simon C. et al., 2021/07/15. Clinical cancer research, 27 (14) pp. 4054-4065. Peer-reviewed.
Enhanced Phenotype Definition for Precision Isolation of Precursor Exhausted Tumor-Infiltrating CD8 T Cells.
Martinez-Usatorre A., Carmona S.J., Godfroid C., Yacoub Maroun C., Labiano S., Romero P., 2020. Frontiers in immunology, 11 p. 340. Peer-reviewed.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University